[Molecular pathology of urogenital tumors : Recommendations from the 2019 International Society of Urological Pathology (ISUP) Consensus Conference].

Hommerding, Oliver; Allory, Yves; Argani, Pedram; Bismar, Tarek A; Bubendorf, Lukas; Canete-Portillo, Sofía; Chaux, Alcides; Chen, Ying-Bei; Cheng, Liang; Cubilla, Antonio L; Egevad, Lars; Gill, Anthony J; Grignon, David J; Hartmann, Arndt; Hes, Ondrej; Idrees, Muhammad T; Kao, Chia-Sui; Knowles, Margaret A; Looijenga, Leendert H J; Lotan, Tamara L; ... (2021). [Molecular pathology of urogenital tumors : Recommendations from the 2019 International Society of Urological Pathology (ISUP) Consensus Conference]. Der Pathologe, 42(3), pp. 310-318. Springer 10.1007/s00292-020-00888-4

[img] Text
292_2020_Article_888.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (387kB) | Request a copy

Comprehensive understanding of molecular principles in cancer and the diversification of oncological therapy promise individual therapeutic concepts, which have not yet found their way into urogenital cancer therapy. In March 2019 the International Society of Urogenital Pathology (ISUP) therefore held a consensus conference on recommendations for molecular diagnostics of genitourinary tumors, which were published in five separate manuscripts and are summarized in this article.In preparation for the conference, a comprehensive survey of current practices for molecular testing of urogenital tumors was carried out by members of the ISUP. At the conference, the results and the corresponding background information were presented by five working groups and recommendations for action for diagnostics were developed. An agreement between 66% of the conference participants was defined as consensus.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Präzisionsonkologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Präzisionsonkologie

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR)

UniBE Contributor:

Rubin, Mark Andrew

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1432-1963

Publisher:

Springer

Language:

German

Submitter:

Marla Rittiner

Date Deposited:

24 Jan 2022 09:52

Last Modified:

05 Dec 2022 16:00

Publisher DOI:

10.1007/s00292-020-00888-4

PubMed ID:

33398501

Uncontrolled Keywords:

Bladder cancer Kidney cancer Molecular biomarker Prostate cancer Targeted therapy

BORIS DOI:

10.48350/163438

URI:

https://boris.unibe.ch/id/eprint/163438

Actions (login required)

Edit item Edit item
Provide Feedback